Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 207,638 | 194,430 | 157,214 | 181,890 | 182,546 |
| Cost of Goods | 4,596 | 3,433 | 2,403 | 2,956 | 2,867 |
| Gross Profit | 203,042 | 190,997 | 154,811 | 178,934 | 179,679 |
| Operating Expenses | 193,419 | 164,755 | 151,798 | 154,629 | 133,948 |
| Operating Income | 10,219 | 26,675 | 3,416 | 25,261 | 46,598 |
| Other Income | 5,024 | 5,017 | 6,202 | 6,700 | 6,345 |
| Pre-tax Income | 15,243 | 31,692 | 9,618 | 31,961 | 52,943 |
| Income Tax | -4,425 | -3,457 | -10,929 | 1,215 | 5,730 |
| Net Income Continuous | 19,668 | 35,149 | 20,547 | 30,746 | 47,213 |
| Net Income | $19,668 | $35,149 | $20,547 | $30,746 | $47,213 |
| EPS Basic Total Ops | 0.19 | 0.33 | 0.19 | 0.29 | 0.45 |
| EPS Basic Continuous Ops | 0.19 | 0.34 | 0.20 | 0.30 | 0.46 |
| EPS Diluted Total Ops | 0.16 | 0.29 | 0.17 | 0.25 | 0.41 |
| EPS Diluted Continuous Ops | 0.16 | 0.29 | 0.17 | 0.26 | 0.42 |
| EPS Diluted Before Non-Recurring Items | 0.16 | 0.29 | 0.17 | 0.26 | 0.41 |
| EBITDA(a) | $10,696 | $27,144 | $3,878 | $14,783 | $47,097 |